Biofrontera Inc.
General ticker "BFRI" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $4.6M (TTM average)
Biofrontera Inc. follows the US Stock Market performance with the rate: 25.8%.
Estimated limits based on current volatility of 4.0%: low 0.79$, high 0.86$
Factors to consider:
- Total employees count: 85 (+4.9%) as of 2023
- Top business risk factors: Operational and conduct risks, Supply chain disruptions, Liquidity and credit risks, Litigation risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.62$, 1.98$]
- 2025-12-31 to 2026-12-31 estimated range: [0.63$, 1.97$]
Financial Metrics affecting the BFRI estimates:
- Positive: with PPE of -0.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Negative: Operating cash flow per share per price, % of -178.81 <= 0.33
- Positive: Investing cash flow per share per price, % of -0.05 > -0.66
- Positive: Inventory ratio change, % of -9.13 <= -0.75
Short-term BFRI quotes
Long-term BFRI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $28.67MM | $34.07MM | $37.30MM |
| Operating Expenses | $47.26MM | $56.75MM | $54.51MM |
| Operating Income | $-18.58MM | $-22.68MM | $-17.21MM |
| Non-Operating Income | $17.97MM | $2.56MM | $-0.53MM |
| Interest Expense | $0.20MM | $0.47MM | $2.11MM |
| R&D Expense | $0.00MM | $0.08MM | $2.09MM |
| Income(Loss) | $-0.61MM | $-20.12MM | $-17.74MM |
| Taxes | $0.03MM | $0.01MM | $0.02MM |
| Profit(Loss)* | $-0.64MM | $-20.13MM | $-17.76MM |
| Stockholders Equity | $23.88MM | $4.79MM | $4.43MM |
| Inventory | $7.17MM | $10.91MM | $6.65MM |
| Assets | $50.88MM | $27.93MM | $22.10MM |
| Operating Cash Flow | $-16.20MM | $-24.89MM | $-10.27MM |
| Capital expenditure | $0.04MM | $0.01MM | $0.06MM |
| Investing Cash Flow | $-5.16MM | $0.62MM | $-0.00MM |
| Financing Cash Flow | $14.02MM | $8.41MM | $14.84MM |
| Earnings Per Share** | $-0.61 | $-13.02 | $-3.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.